Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) and other hematologic malignancies

Success of tyrosine kinase inhibitors (TKIs) in chronic myeloid leukemia (CML) has given patients hope for a long disease-free-survival. A longer survival raises the question of late effects, including development of another malignancy. Records of 1445 patients with CML/myeloproliferative neoplasm o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Verma, Dushyant, Kantarjian, Hagop, Strom, Sara S., Rios, Mary Beth, Jabbour, Elias, Quintas-Cardama, Alfonso, Verstovsek, Srdan, Ravandi, Farhad, O'Brien, Susan, Cortes, Jorge
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society of Hematology 2011
Schlagworte:
Clinical Trials and Observations
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3291487/
https://ncbi.nlm.nih.gov/pubmed/21846902
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2011-06-362889
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge